In this study, we used carbon tetrachloride (CCl4) to induce liver fibrosis in mice and TGF-β to activate HSC-T6 cells, and then evaluated the effects of indirubin on in vivo mouse model and in vitro HSC-T6 cells. The gene discussed is TGFB1; the disease is Hepatic fibrosis.